Journal of King Saud University: Science (Nov 2022)

CpG methylation analysis of tumour suppressor gene and expression of Cathepsin B in renal cell carcinoma

  • P. Vijayaragavan,
  • M.A. Rathi,
  • V.K. Gopalakrishnan,
  • Rami Adel Pashameah,
  • Atif Abdulwahab A. Oyouni,
  • Osama M. Al-Amer,
  • Waseem AlZamzami,
  • Hussam Awwadh E. Althagafi,
  • V. Duraipandiyan,
  • Fahad Alharthi

Journal volume & issue
Vol. 34, no. 8
p. 102330

Abstract

Read online

Renal cell carcinoma (RCC) is one of the most common types of cancers, representing about 2.3% of all malignancies throughout the world. In RCC, Cathepsin B (CtsB) plays a major role in signalling pathways, processing, and intracellular protein degradation. CtsB is involved in tumour cell invasion, matrix remodelling and metastasis and this mechanism was controlled by natural inhibitors. In this study targeted methylation changes were analyzed in primary renal cancer and metastatic tissues and the expression of CtsB was analyzed in RCC and compared with normal cells. The levels of CpG methylation of Runt-trelated transcription factor 3 (RUNX3) were analyzed. The decreased level of RUNX3 was observed in metastatic tissues due to CpG methylation. The increased methylation in CpG islands increased metastasis and was associated with RUNX3. The amount of CtsB mRNA was high in the RCC tissues than in surrounding normal tissues. Increased expression of CtsB was observed in RCC. Overexpression of CtsB was confirmed by Western blotting analysis and expression of CtsB increased the proliferation of RCC. The present finding revealed that CtsB has a major role in the development and proliferation of RCC.

Keywords